Clinical Trial Update: A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating efficacy and safety of AK101 in psoriasis vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• AK101

Snippet

Sponsor: Akeso | Conditions: Psoriasis Vulgaris | Phase 3 | Status: COMPLETED